IMPROVEMENTS IN SCALP OUTCOMES WITH ROFLUMILAST FOAM 0.3% FOR PSORIASIS OF THE SCALP AND BODY FROM THE PHASE 3 ARRECTOR TRIAL
Recommended Citation
Stein Gold LF, Strober B, Vender R, Chovatiya R, Armstrong A, Krupa D, Jaworski JC, Seal MS, Hanna D, Stephenson B. IMPROVEMENTS IN SCALP OUTCOMES WITH ROFLUMILAST FOAM 0.3% FOR PSORIASIS OF THE SCALP AND BODY FROM THE PHASE 3 ARRECTOR TRIAL. Value Health 2025; 28(12).
Document Type
Conference Proceeding
Publication Date
12-1-2025
Publication Title
Value Health
Volume
28
Issue
12
COinS
